New Yorkers hate to think of their city as second to anywhere, but when it comes to the life sciences sector, the Big Apple has ranked in the back of the pack, behind the Bay Area, the Research Triangle in North Carolina and (shudder) Boston.
“New York City has the second-largest academic biotech medical infrastructure and funding in the United States, behind only Boston,” said Dr. Richard Lifton, president of Rockefeller University. “And yet we do not have a commensurate sized biotech community.”
But that is changing quickly.
During the summer, Mayor Bill de Blasio promised a half-billion dollar investment in lab space development and life sciences research.
→ Continue reading at Crain's New York Business